NGVT
Ingevity Corporation NYSE$77.10
Mkt Cap $2.7B
52w Low $36.18
98.7% of range
52w High $77.62
50d MA $71.03
200d MA $60.63
P/E (TTM)
-16.5x
EV/EBITDA
88.4x
P/B
92.5x
Debt/Equity
41.8x
ROE
-562.6%
P/FCF
7.8x
RSI (14)
—
ATR (14)
—
Beta
1.27
50d MA
$71.03
200d MA
$60.63
Avg Volume
331.4K
About
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 0.67 | 0.58 | -12.8% | 69.60 | -5.3% | +1.3% | +3.5% | +2.9% | +1.5% | +0.4% | — |
| Nov 5, 2025 | AMC | 0.68 | 1.31 | +92.6% | 54.46 | -2.5% | -15.2% | -11.1% | -8.4% | -9.1% | -9.8% | — |
| Aug 4, 2025 | AMC | 1.02 | 1.39 | +36.3% | 40.85 | +14.6% | +21.3% | +19.7% | +23.6% | +25.5% | +27.8% | — |
| May 5, 2025 | AMC | 0.74 | 0.99 | +33.8% | 35.52 | +3.3% | +10.4% | +10.4% | +13.4% | +13.9% | +21.2% | — |
| Feb 18, 2025 | AMC | 0.29 | 0.95 | +227.6% | 45.84 | +1.7% | +5.3% | +2.0% | +0.4% | +0.6% | +4.8% | — |
| Oct 29, 2024 | AMC | 0.60 | 1.10 | +83.3% | 35.32 | +20.0% | +17.9% | +18.3% | +18.9% | +18.7% | +22.8% | — |
| Jul 31, 2024 | AMC | 1.05 | 1.01 | -3.8% | 45.89 | -13.8% | -7.1% | -10.2% | -22.8% | -24.4% | -24.1% | — |
| May 1, 2024 | AMC | 0.37 | 0.52 | +40.5% | 51.89 | +1.1% | +5.6% | +3.2% | +3.8% | +3.5% | +4.1% | — |
| Feb 21, 2024 | AMC | -0.13 | 0.21 | +261.5% | 44.97 | +7.9% | +5.4% | +8.9% | +7.0% | +3.6% | +0.7% | — |
| Nov 1, 2023 | AMC | 1.22 | 1.21 | -0.8% | 39.25 | +1.7% | +7.7% | +9.1% | +2.1% | +0.2% | -0.8% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $70.52 | $69.84 | -1.0% | +2.1% | +1.6% | +0.2% | -0.9% | -4.7% |
| Jan 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $66.25 | $66.49 | +0.4% | -0.5% | -0.7% | +1.5% | +5.3% | +8.9% |
| Dec 19 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $59.59 | $59.79 | +0.3% | -1.6% | +0.3% | -0.1% | +0.7% | +0.9% |
| Dec 10 | BMO Capital | Maintains | Outperform → Outperform | — | $56.05 | $56.61 | +1.0% | +5.0% | +7.9% | +5.0% | +2.6% | +2.2% |
| Nov 12 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.53 | $49.57 | +0.1% | -0.8% | +2.0% | -0.3% | -4.9% | -3.1% |
| Sep 5 | BMO Capital | Maintains | Outperform → Outperform | — | $58.88 | $59.00 | +0.2% | +1.5% | +3.2% | -0.1% | -3.0% | -0.2% |
| Aug 7 | BMO Capital | Maintains | Outperform → Outperform | — | $48.89 | $49.90 | +2.1% | +3.3% | +4.9% | +6.8% | +10.2% | +13.5% |
| Jul 14 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $47.56 | $47.47 | -0.2% | -1.0% | -4.2% | -4.4% | -2.6% | -2.9% |
| May 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $39.20 | $38.80 | -1.0% | +0.1% | +2.8% | +3.2% | +9.8% | +10.2% |
| Apr 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $29.88 | $28.92 | -3.2% | +11.8% | +4.7% | +7.0% | +6.2% | +6.4% |
Recent Filings
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Ingevity received $65 million in cash from divesting a non-core road markings business, reducing debt and refocusing on higher-margin specialty chemicals, which should improve returns on remaining operations.
Apr 15
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
NGVT signed a material agreement valued at $512.1 million, likely representing a major contract win or partnership that could significantly boost revenue and improve growth prospects for investors.
Mar 30
8-K · 7.01
! Medium
Ingevity Corporation -- 8-K 7.01: Regulation FD Disclosure
Ingevity disclosed that corporate administrative and NYSE compliance costs are centrally managed rather than allocated to specific business segments, affecting how investors should evaluate divisional performance metrics.
Feb 25
8-K · 5.02
!!! Very High
Ingevity Corporation -- 8-K 5.02: Executive Change
The departure of Ingevity's executive signals potential uncertainty in strategy execution, which could concern investors about leadership continuity and near-term operational stability.
Feb 23
Data updated apr 26, 2026 2:59pm
· Source: massive.com